Karolinska Development
AB (publ)
org. nr. 556707-5048
Registered office: Solna
© Karolinska Development 2010

Conny Bogentoft
CEO

PhD in Medicinal Chemistry, Associate Professor in Pharmaceutical Chemistry. Has, with more than 30 years' experience of pharmaceutical industry, as senior R&D management positions and as a member of board of directors of Galenica AB, demonstrated his ability to successfully plan, implement and develop clinical and business strategies. Previous appointments include Vice President of Astra Arcus, President of Kabi Invent, Research Director at Aco Läkemedel, and Chairman of the Swedish Academy of Pharmaceutical Sciences.

Number of shares held in Karolinska Development AB: 29 433.

Gunnar Casserstedt
CFO

BSc in Business Administration, brings 30 years of global financial experience in the pharmaceutical and biotechnology industry. Previous appointments include several positions in senior management including Vice President R&D Finance at Pharmacia Inc. and CFO at Sopherion Therapeutics Inc.

Hans-Peter Ekre
Investment Manager

BSc, PhD studies in Immunology. Brings 25 years of experience in senior management positions in drug discovery and drug development in the pharmaceutical industry, including Kabi-Pharmacia and Director of Pharmacology at Astra Draco, and is frequently entrusted as advisor within the research, health and medical care sectors in Sweden.

Ola Flink
Investment Manager

Pharmacist. Brings experience from more than 30 years in the pharmaceutical drug development industry, including AstraZeneca, Apoteksbolaget, ACO Läkemedel and Kabi. Deputy member of the board of directors of Kampavata AB. Previous appointments include CEO and board member of Karolinska Institutet Innovations AB.

Carl Harald Janson
Investment Manager

MD, PhD from Karolinska Institutet, CEFA from Stockholm School of Economics. Brings over 25 years of experience in medicine, pharmaceutical industry and investment management. Previous appointments include Medical Adviser Clinical Research, and Director Immunology, Preclinical R&D, Astra Arcus AB, Senior Financial Analyst at Hagströmer & Qviberg Fondkommission AB and Danske Securities, and Senior Portfolio Manager at Carnegie Investment Bank AB.

Otto Skolling
Investment Manager

MSc in Chemistry. Some 15 years of broad-based pharmaceutical and med tech. industry experience, including product development, business development and project management gained through management positions at Novozymes, Siemens Life Support Systems and Pharmacia & Upjohn.